86 related articles for article (PubMed ID: 2767744)
1. Mitoxantrone & adriamycin cytotoxicity enhanced by reserpine in human chronic myeloid leukaemia cells.
Chitnis MP; Kamath NS; Advani SH
Indian J Med Res; 1989 Jun; 90():197-202. PubMed ID: 2767744
[TBL] [Abstract][Full Text] [Related]
2. Dipyrone enhances intracellular accumulation and cytotoxicity of adriamycin in human chronic myeloid leukemia cells.
Chitnis MP; Kamath NS; Parekh HK; Advani SH
Neoplasma; 1991; 38(2):185-91. PubMed ID: 2041578
[TBL] [Abstract][Full Text] [Related]
3. Response of human chronic myeloid leukemia cells to mitoxantrone cytotoxicity: potentiation by bepridil, a calcium channel antagonist.
Parekh HK; Shallom JM; Advani SH; Chitnis MP
Neoplasma; 1991; 38(6):575-81. PubMed ID: 1766484
[TBL] [Abstract][Full Text] [Related]
4. Abrogation of human chronic myeloid leukemia cells insensitivity to adriamycin and mitoxanthrone cytotoxicity by quinidine.
Parekh HK; Advani SH; Chitnis MP
Neoplasma; 1990; 37(6):717-25. PubMed ID: 2274089
[TBL] [Abstract][Full Text] [Related]
5. Modulation of mitoxantrone cytotoxicity by verapamil in human chronic myeloid leukemia cells.
Satyamoorthy K; Chitnis MP; Pradhan SG; Advani SH
Oncology; 1989; 46(2):128-31. PubMed ID: 2710477
[TBL] [Abstract][Full Text] [Related]
6. In vitro modulation of adriamycin and mitoxantrone cytotoxicity by hyperthermia and diazepam, in human chronic myeloid leukemia cells.
Juvekar AS; Chitnis MP; Advani SH
Neoplasma; 1987; 34(2):199-204. PubMed ID: 3474531
[TBL] [Abstract][Full Text] [Related]
7. Effect of mitoxantrone on human chronic myeloid leukemia cells in vitro, combined with hyperthermia.
Juvekar AS; Chitnis MP; Adwankar MK; Advani SH
Neoplasma; 1986; 33(4):477-82. PubMed ID: 3463880
[TBL] [Abstract][Full Text] [Related]
8. Imatinib increases cytotoxicity of melphalan and their combination allows an efficient killing of chronic myeloid leukemia cells.
Giallongo C; La Cava P; Tibullo D; Parrinello N; Barbagallo I; Del Fabro V; Stagno F; Conticello C; Romano A; Chiarenza A; Palumbo GA; Di Raimondo F
Eur J Haematol; 2011 Mar; 86(3):216-25. PubMed ID: 21198861
[TBL] [Abstract][Full Text] [Related]
9. FK506 reverses adriamycin resistance in a multidrug-resistant human leukemia cell line.
Natazuka T
Kobe J Med Sci; 1992 Dec; 38(6):347-63. PubMed ID: 1284834
[TBL] [Abstract][Full Text] [Related]
10. The in vitro cytotoxic effect of mitoxantrone in combination with fludarabine or pentostatin in B-cell chronic lymphocytic leukemia.
Morabito F; Callea I; Console G; Stelitano C; Sculli G; Filangeri M; Oliva B; Musolino C; Iacopino P; Brugiatelli M
Haematologica; 1997; 82(5):560-5. PubMed ID: 9407721
[TBL] [Abstract][Full Text] [Related]
11. Sensitization of chronic myeloid leukemia cells to adriamycin cytotoxicity by clofibrate.
Parekh H; Satyamoorthy K; Advani S; Chitnis M
Tumori; 1990 Feb; 76(1):18-21. PubMed ID: 2321268
[TBL] [Abstract][Full Text] [Related]
12. Schedule-dependent interaction of cytarabine plus doxorubicin or cytarabine plus mitoxantrone in acute myelocytic leukemia cells in culture.
Fountzilas G; Inoue S; Ohnuma T
Leukemia; 1990 May; 4(5):321-4. PubMed ID: 2388478
[TBL] [Abstract][Full Text] [Related]
13. ABT-737 is a useful component of combinatory chemotherapies for chronic myeloid leukaemias with diverse drug-resistance mechanisms.
Kuroda J; Kimura S; Andreeff M; Ashihara E; Kamitsuji Y; Yokota A; Kawata E; Takeuchi M; Tanaka R; Murotani Y; Matsumoto Y; Tanaka H; Strasser A; Taniwaki M; Maekawa T
Br J Haematol; 2008 Jan; 140(2):181-90. PubMed ID: 18028486
[TBL] [Abstract][Full Text] [Related]
14. Bepridil enhances adriamycin-induced DNA biosynthesis inhibition in human myeloid leukemia cells.
Parekh H; Advani S; Chitnis M
Sel Cancer Ther; 1990; 6(4):183-91. PubMed ID: 2094938
[TBL] [Abstract][Full Text] [Related]
15. Single and combination treatment with vitamin K3 and adriamycin: in vitro effects on cell survival and DNA damage in human chronic myeloid leukemia cells.
Parekh H; Chavan S; Advani S; Chitnis M
Sel Cancer Ther; 1991; 7(3):127-35. PubMed ID: 1771299
[TBL] [Abstract][Full Text] [Related]
16. Topotecan-induced topoisomerase IIalpha expression increases the sensitivity of the CML cell line K562 to subsequent etoposide plus mitoxantrone treatment.
Chen S; Gomez SP; McCarley D; Mainwaring MG
Cancer Chemother Pharmacol; 2002 May; 49(5):347-55. PubMed ID: 11976828
[TBL] [Abstract][Full Text] [Related]
17. Amelioration of doxorubicin resistance by pentoxifylline in human chronic myeloid leukemia cells in vitro.
Viladkar A; Juvekar A; Chitnis M; Advani S
Sel Cancer Ther; 1991; 7(3):119-26. PubMed ID: 1771298
[TBL] [Abstract][Full Text] [Related]
18. Interaction of cyclosporin A and etoposide. Clinical and in vitro assessment in blast phase of chronic myeloid leukaemia.
Maia RC; Noronha H; Vasconcelos FC; Rumjanek VM
Clin Lab Haematol; 1997 Sep; 19(3):215-7. PubMed ID: 9352149
[TBL] [Abstract][Full Text] [Related]
19. Differential alteration of cellular lipids in drug sensitive and resistant P388 leukemia cells by clofibrate: effects on mitoxantrone cytotoxicity.
Parekh H; Chitnis M
Tumori; 1991 Apr; 77(2):105-11. PubMed ID: 2048221
[TBL] [Abstract][Full Text] [Related]
20. Estrogen-induced potentiation of DNA damage and cytotoxicity in human breast cancer cells treated with topoisomerase II-interactive antitumor drugs.
Epstein RJ; Smith PJ
Cancer Res; 1988 Jan; 48(2):297-303. PubMed ID: 2825970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
